# Cyclophosphamide and Fludarabine to Treat Lupus Nephritis

> **NCT00001676** · PHASE1 · COMPLETED · sponsor: **National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)** · enrollment: 15 (—)

## Conditions studied

- Glomerulonephritis
- Lupus Nephritis
- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** SQ Fludarabine

## Key facts

- **NCT ID:** NCT00001676
- **Lead sponsor:** National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-01
- **Primary completion:** —
- **Final completion:** 2002-11
- **Target enrollment:** 15 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001676, "Cyclophosphamide and Fludarabine to Treat Lupus Nephritis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00001676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*